KRAS and lung carcinoma: Our laboratory has used an orthotopic and immunocompetent mouse model to study how K-Ras–mutant lung cancers respond to the immune system (Poczobutt et al, 2016a, 2016b; Li et al, 2017; Kwak et al, 2018).